Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause

Summary

The purpose of this study is to assess the safety and efficacy of desvenlafaxine succinate (DVS) for treatment of moderate to severe vasomotor symptoms (VMS) that are associated with menopause, and also to assess the effects of DVS on sleep parameters and health outcomes indicators.

Timeline

Start

2004-09

Primary completion

—

Completion

2005-07

Drugs

Indications